Hep C

Having spent a decade (of pure futility) in hepatitis C (HCV) research in my former career, I have spent a fair amount of time since then writing about the astounding progress made over a 25-year period.
The headlines didn't exactly jump off the page: "BioCryst's Zika drug shows promise in mice." Big deal.
Before we start, congratulations are in order.
Get the latest news on the costly Hepatitis C drug, why C-sections have skyrocketed in numbers, and the real reason behind the lack of research on antibiotic research